SuperGen Initiates Phase II Combination Trial of Orathecin™ and Gemcitabine in Chemotherapy Naive Pancreatic Cancer Patients

SuperGen Initiates Phase II Combination Trial of Orathecin™ and Gemcitabine in Chemotherapy Naive Pancreatic Cancer Patients